2,6,4-Trihydroxy-4-methoxybenzophenone
CAS No. 55051-85-9
2,6,4-Trihydroxy-4-methoxybenzophenone ( —— )
产品货号. M31575 CAS No. 55051-85-9
2,6,4'-Trihydroxy-4-methoxybenzophenone shows weak inhibitory activity of testosterone 5alpha-reductase, it also shows significant inhibition of pancreatic lipase activity.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥13365 | 有现货 |
|
50MG | 获取报价 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
5MG | ¥13365 | 有现货 |
|
50MG | 获取报价 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称2,6,4-Trihydroxy-4-methoxybenzophenone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述2,6,4'-Trihydroxy-4-methoxybenzophenone shows weak inhibitory activity of testosterone 5alpha-reductase, it also shows significant inhibition of pancreatic lipase activity.
-
产品描述2,6,4'-Trihydroxy-4-methoxybenzophenone shows weak inhibitory activity of testosterone 5alpha-reductase, it also shows significant inhibition of pancreatic lipase activity. 2,6,4'-Trihydroxy-4-methoxybenzophenone has neurotrophic activity, it induced neurite outgrowth in PC-12 cells at concentration of 50 microg/ml. 2,6,4a?2-Trihydroxy-4-methoxybenzophenone exhibits low cytotoxic effect against HeLa and 3T3 cell lines with IC50 values of 132 ug/ml and 158 ug/ml, repectively. It also shows antioxidant activity on DPPH with IC50 of 10.57 ug/mL.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number55051-85-9
-
分子量260.2
-
分子式C14H12O5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Isophysalin A
Isophysalin A exhibits anti-inflammatory activitiy, it exhibits conjugating abilities with glutathione and also shows significant nitric oxide (NO) production inhibiting activities.
-
Ethyl (E)-ferulate
Ethyl ferulate could be used for therapeutic purposes as a potent inducer of HO-1 for the protection of brain cells against oxidative and neurodegenerative conditions.
-
N-ε-propargyloxycarb...
N-ε-propargyloxycarbonyl-L-lysine hydrochloride is a modified amino acid for cancer therapy development.